Albuterol and Warm type haemolytic anaemia - a phase IV clinical study of FDA data
Warm type haemolytic anaemia is reported only by a few people who take Albuterol.
The phase IV clinical study analyzes which people take Albuterol and have Warm type haemolytic anaemia. It is created by eHealthMe based on reports of 133,133 people who have side effects while taking Albuterol from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
133,133 people reported to have side effects when taking Albuterol.
Among them, 1 person (0.0%) has Warm type haemolytic anaemia.
What is Albuterol?
Albuterol has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 134,909 Albuterol users for its effectiveness, alternative drugs and more.
What is Warm type haemolytic anaemia?
Warm type haemolytic anaemia (red cell destruction due to warm antibody self defence) is found to be associated with 171 drugs and 116 conditions by eHealthMe.
Number of Albuterol and Warm type haemolytic anaemia reports submitted per year:
Gender of people who have Warm type haemolytic anaemia when taking Albuterol *:
- female: 0.0 %
- male: 100 %
Age of people who have Warm type haemolytic anaemia when taking Albuterol *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
Common conditions people have *:
- Lung Adenocarcinoma (a form of non-small cell lung cancer): 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Albuterol and have Warm type haemolytic anaemia?Check whether Warm type haemolytic anaemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Warm type haemolytic anaemia and when was it recovered:
Expand to all the drugs that have ingredients of albuterol:
Alternative drugs to, pros and cons of Albuterol:
- Albuterol (134,909 reports)
Common Albuterol side effects:
- Breathing difficulty: 17,779 reports
- Drug ineffective: 8,720 reports
- Fatigue (feeling of tiredness): 8,683 reports
- Pneumonia: 8,337 reports
- Asthma: 7,968 reports
- Pain: 7,595 reports
- Cough: 7,384 reports
- Headache (pain in head): 7,297 reports
Browse all side effects of Albuterol:a b c d e f g h i j k l m n o p q r s t u v w x y z
Warm type haemolytic anaemia treatments and more:
- Warm type haemolytic anaemia (205 reports)
COVID vaccines that are related to Warm type haemolytic anaemia:
- Warm type haemolytic anaemia in Moderna COVID Vaccine
- Warm type haemolytic anaemia in Pfizer BioNTech Covid Vaccine
- Warm type haemolytic anaemia in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Warm type haemolytic anaemia:
- Warm type haemolytic anaemia (171 drugs)
All the conditions that are associated with Warm type haemolytic anaemia:
- Warm type haemolytic anaemia (116 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on albuterol (the active ingredients of Albuterol) and Albuterol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Singulair and Jakafi drug interaction - 4 seconds ago
- Alprazolam and Warm Type Haemolytic Anaemia - 4 seconds ago
- Excedrin and Urinary Incontinence - 8 seconds ago
- Singulair and Cortisone Acetate drug interaction - 9 seconds ago
- Methotrexate and Tension Headache - 11 seconds ago
- Singulair and Foradil drug interaction - 14 seconds ago
- Singulair and Tysabri drug interaction - 15 seconds ago
- Singulair and Rebif drug interaction - 16 seconds ago
- Docefrez and Aspirin drug interaction - 17 seconds ago
- Singulair and Vitamin E drug interaction - 18 seconds ago